Press release
Outlook on the Artificial Intelligence in Cancer Diagnostics Market: Major Segments, Strategic Developments, and Leading Companies
Artificial Intelligence In Cancer Diagnostics Market
Growth Forecast and Market Size of Artificial Intelligence in Cancer Diagnostics
The artificial intelligence in cancer diagnostics market is anticipated to witness substantial expansion over the coming years. By 2030, its valuation is projected to reach $2.02 billion, propelled by an impressive compound annual growth rate (CAGR) of 30.9%. This surge is fueled by growing demand for early cancer detection, the rising adoption of precision medicine, enhancements in AI-powered diagnostic accuracy, increased funding for oncology research, and the integration of genomics with imaging data. Key trends shaping this market include AI-assisted medical imaging analysis, advancements in early cancer detection tools, incorporation of predictive oncology analytics, automation in diagnostic workflows, and the widespread use of decision support systems.
Download a free sample of the artificial intelligence in cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR
Leading Corporations Advancing the Artificial Intelligence in Cancer Diagnostics Market
Several major companies are at the forefront of innovation and competition within this market. Notable players include Microsoft Corporation, Siemens, Roche Holding AG, Google LLC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, and SkinVision B.V.
Strategic Acquisitions Strengthen Market Positions
In July 2025, RadNet Inc., a U.S.-based company specializing in diagnostic imaging and digital health, acquired iCAD Inc. The terms of this deal were not disclosed. This acquisition aims to enhance RadNet's capabilities in cancer screening by incorporating iCAD's AI-powered breast health technologies, which focus on mammography detection, risk assessment, and workflow optimization. iCAD Inc., a U.S. firm, is recognized for its artificial intelligence solutions designed to improve breast cancer detection and screening efficiency.
View the full artificial intelligence in cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR
Collaborations Drive Innovation in AI-Powered Cancer Diagnostics
Companies in this market are increasingly entering strategic partnerships to accelerate the adoption of AI-driven digital pathology tools that support cancer diagnosis. Such alliances allow businesses to combine resources and expertise for mutual benefit. For example, in October 2023, F. Hoffmann-La Roche AG, headquartered in Switzerland, formed a collaboration with Israel's Ibex Medical Analytics and the U.S.-based Amazon Web Services. This partnership enables pathology labs to utilize the navify Digital Pathology software platform, integrating Ibex's AI-powered decision support to assist doctors in diagnosing breast and prostate cancers. The collaboration leverages AWS's cloud infrastructure to provide scalable, sustainable digital pathology and AI solutions, helping labs and pathologists unlock the full potential of digital transformation.
Detailed Segmentation of the Artificial Intelligence in Cancer Diagnostics Market
This market is categorized into several distinct segments to provide comprehensive insights:
1) By Component:
- Software Solutions
- Hardware
- Services
2) By Cancer Type:
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Other Types
3) By Application:
- Screening and Diagnosis
- Tumor Identification
- Surveillance
- Treatment
4) By End-User:
- Hospitals
- Medical Research Institutes
- Diagnostic Centers
- Contract Research Organizations
Further breakdowns include:
- Software Solutions such as Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, and Data Management Platforms.
- Hardware including Imaging Devices, Biomarkers Detection Equipment, and Computing Infrastructure.
- Services encompassing Consulting, Implementation, Maintenance and Support, and Training.
This structured segmentation highlights the diverse components and applications contributing to the rapid evolution of the artificial intelligence in cancer diagnostics market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Outlook on the Artificial Intelligence in Cancer Diagnostics Market: Major Segments, Strategic Developments, and Leading Companies here
News-ID: 4503589 • Views: …
More Releases from The Business Research Company
Prenatal DNA Sequencing Market Analysis Highlights Growth To $6.08 Billion By 20 …
The prenatal DNA sequencing market is on the cusp of significant expansion, driven by technological advancements and growing demand for precise prenatal diagnostics. As this field evolves, it opens new pathways for improving fetal health assessment and personalized medicine. Let's explore the market's potential size, key players, emerging trends, and segment breakdowns shaping its future.
Forecasted Growth and Market Size of Prenatal DNA Sequencing
The prenatal DNA sequencing market is…
Preimplantation Genetic Testing Market Study Highlights How Industry Demand Is E …
The preimplantation genetic testing sector is poised for significant expansion as advancements in reproductive technologies continue to evolve. Rising demand for personalized treatment options and innovative genetic screening techniques are key factors shaping the market's promising outlook. Let's explore the market's size projections, influential players, emerging trends, and the main segments driving growth through 2030.
Preimplantation Genetic Testing Market Size and Growth Outlook
The preimplantation genetic testing market is set…
Predictive Genetic Counselling Market Research Reveals Strong 15.9% CAGR Outlook …
The predictive genetic counselling sector is gaining significant traction as personalized medicine advances and genomics become integral to healthcare. With rising technological adoption and patient awareness, the market is positioned for impressive growth, driven by innovations and expanding service offerings that cater to preventive and precision medicine.
Projected Growth of the Predictive Genetic Counselling Market by 2030
The market for predictive genetic counselling is anticipated to expand swiftly, reaching a…
Preclinical Assets Market Trends Support A 9.8% CAGR Outlook Through The Forecas …
The preclinical assets sector is poised for substantial expansion as the pharmaceutical and biotechnology industries continue to prioritize early-stage drug discovery and development. Advances in modeling techniques and growing demand for more predictive research tools are setting the stage for robust growth through the end of the decade. Let's explore the current market size, key players, emerging trends, and detailed segment breakdowns shaping this dynamic industry.
Preclinical Assets Market Size and…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
